Until recently, oncologists had to comb through mountains of raw data of cancer patients to draw any meaningful information, but now Tempus has come to change that. Lack of standardized data has been one of the biggest impediments to effective cancer treatments. Most of the genomic and therapeutic information on people who are battling with various forms of cancer exists in the form of doctors’ notes. This reality lives doctors with very little information to act upon whenever they are prescribing treatment to their patients.
Entrepreneur Eric Lefskofsky has partnered with other players in the field of medicine to champion the next frontier in cancer treatment which is data-driven precision medicine. Through a joint venture called Tempus, the seasoned businessman is expected to revolutionize healthcare as far autoimmune diseases such as cancer are concerned and read full article.
It never dawned on Eric Lefkofsky that he could find his calling in the field of medicine. Eric had always been an investor in the area of technology and had developed several disruptive brands in this sector. In 2015, Eric Lefkofsky changed his course in business and decided to venture into medical research when someone close to him needed cancer treatment. It was at this moment of horror and pain that Eric made a life-changing discovery. Eric noticed that oncologists were working with limited data. Most of the information that existed was in forms which they couldn’t draw any meaningful analyses from it.
Eric decided to co-found a company that could speed up research in the medical field of oncology. Eric wanted to put effective therapies in the hands of cancer patients as soon as he could. Through Tempus, Eric’s dream is beginning to take shape one step after the other. Already, the company has begun analyzing medical records from over 1,000 breast cancer patients with the aim of drawing analytics that can help scientists come up with data-driven precision medicine and what Eric knows.
When a doctor is handling various cancer patients, they can compare the patient’s clinical and genomic data against that of other patients who are living with the same type of cancer. With various cases of cancer under one pool, doctors can be able to know what works and what doesn’t.
Apart from making a lot of progress in the field of entrepreneurship, Eric Lefkofsky is also a seasoned humanitarian. He is involved with initiatives that aim at making the world a better place for everyone and Eric’s lacrosse camp.